Michael Scolaro

Michael Scolaro

Oct 08, 2017

Group 6 Copy 155
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can low carbohydrate ketogenic diets inhibit cancers?

Insulin is a hormone which supports growth of normal cells, but also of cancers. A very low carbohydrate (VLC...

Human placentophagy: What is the microbial composition of raw and processed placental tissue?

Placentophagy is gaining in popularity as supporters of this behavior claim it has the ability to improve lactation...

What can we do to improve survival in babies with respiratory distress in Bangladesh?

Respiratory Distress is a treatable disease which kills hundreds of thousands of babies every year. Most of...

Backer Badge Funded